Neural Regeneration Research ›› 2015, Vol. 10 ›› Issue (9): 1390-1392.doi: 10.4103/1673-5374.165502

Previous Articles     Next Articles

Epigallocatechin-3-gallate treatment to promote neuroprotection and functional recovery after nervous system injury

Pere Boadas-Vaello, Enrique Verdú   

  1. Research Group of Clinical Anatomy, Embryology, and Neuroscience (NEOMA), Universitat de Girona, Faculty of Medicine, Department of Medical Sciences, Girona, Spain
  • Received:2015-08-01 Online:2015-09-28 Published:2015-09-28
  • Contact: Pere Boadas-Vaello, Ph.D., pere.boadas@udg.edu.
  • Supported by:

    The present work was funded by Accions Singulars de R+D (Sing 12/17) del Vicerectorat de Recerca de la Universitat de Girona, Girona, Spain.

PDF

578

Abstract:

The epigallocatechin-3-gallate (EGCG) treatment may be a potential drug to promote neuroprotection and functional recovery after nervous system injury. However, additional experimental research will be necessary to further explore the biological mechanisms of this polyphenol in order to become a suitable and safe therapeutic treatment.